Cymabay Therapeutics Inc. (NASDAQ:CBAY) Provide Corporate Updates Indicating Initiation Of ENHANCE Study Of Seladelpar l In Q42018
CymaBay Therapeutics Inc. (NASDAQ:CBAY) gained 5% in the last trading session to close at $13.22...
Read More
Author: Ash
PTC Therapeutics Inc. (NASDAQ:PTC) Report Revenue Of $86.3 In Q4 Driven By Sales Of Emflaza And Translarna
PTC Therapeutics Inc. (NASDAQ:PTC) lost 1.3% in the last trading sessions to close at $33.42 at...
Read More
Coheres Biosciences Inc. (NASDAQ:CHRS) Report Completion Of UDENYCA Which Helped Offset Expenses In Q42018
Coheres Biosciences Inc. (NASDAQ:CHRS) gained 1.49% in the previous trading session to close at...
Read More
Cerus Corporation (NASDAQ:CERS) Announces Fourth Quarter and Full Year 2018 Financial Results
Cerus Corporation (NASDAQ:CERS) closed Thursday’s trading session at $6.48, almost two weeks...
Read More
Radius Health Inc (NASDAQ:RDUS) Reports Its 2018 Fourth Quarter and Full Year Financial and Operating Figures
Radius Health Inc (NASDAQ:RDUS) closed Thursday’s trading session at $18.28, a week after it...
Read More
